Sort

Search

Search Bar
17/02/2023 A City Surveillance System for Social Health Inequalities: The Case of Barcelona
Borrell C., Palència L., Marí-Dell’Olmo M., Bartoll X., Gotsens M., Pasarín M.I., Artazcoz L., Rodríguez-Sanz M., López M.J., Pérez K.. A City Surveillance System for Social Health Inequalities: The Case of Barcelona. International Journal of Environmental Research and Public Health. 2023; 20(4)DOI:10.3390/ijerph20043536. PMID:36834231. IF:(Q/D).
15/02/2023 Glucocorticoid-based pharmacotherapies preventing PTSD
Florido, A, Velasco, ER, Monari, S, Cano, M, Cardoner, N, Sandi, C, Andero, R, Perez-Caballero, L. Glucocorticoid-based pharmacotherapies preventing PTSD. NEUROPHARMACOLOGY. 2023; 224DOI:10.1016/j.neuropharm.2022.109344. PMID:36402246. IF:4.600(Q1/2D).
15/02/2023 Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease
Shi L., Xu J., Green R., Wretlind A., Homann J., Buckley N.J., Tijms B.M., Vos S.J.B., Lill C.M., Kate M.T., Engelborghs S., Sleegers K., Frisoni G.B., Wallin A., Lleó A., Popp J., Martinez-Lage P., Streffer J., Barkhof F., Zetterberg H., Visser P.J., Lovestone S., Bertram L., Nevado-Holgado A.J., Proitsi P., Legido-Quigley C.. Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2023; 19(8)DOI:10.1002/alz.12961. PMID:36790009. IF:13.100(Q1/1D).
14/02/2023 Corrigendum to “SELNET clinical practice guidelines for soft tissue sarcoma and GIST” [Cancer Treat. Rev. 102 (2021) 102312] (Cancer Treatment Reviews (2022) 102, (S0305737221001602), (10.1016/j.ctrv.2021.102312))
Blay J.Y., Hindi N., Bollard J., Aguiar S., Jr., Angel M., Araya B., Badilla R., Bernabeu D., Campos F., Caro-Sánchez C.H.S., Carvajal B., Carvajal Montoya A., Casavilca-Zambrano S., Castro-Oliden V., Chacón M., Clara M., Collini P., Correa Genoroso R., Costa F.D., Cuellar M., dei Tos A.P., Dominguez Malagon H.R., Donati D., Dufresne A., Eriksson M., Farias-Loza M., Fernandez P., Frezza A.M., Frisoni T., Garcia-Ortega D.Y., Gelderblom H., Gouin F., Gómez-Mateo M.C., Gronchi A., Haro J., Huanca L., Jimenez N., Karanian M., Kasper B., Lopes David B.B., Lopez-Pousa A., Lutter G., Martinez-Said H., Martinez-Tlahuel J., Mello C.A., Morales Pérez J.M., Moura David S., Nascimento A.G., Ortiz-Cruz E.J., Palmerini E., Patel S., Pfluger Y., Provenzano S., Righi A., Rodriguez A., Salas R., Santos T.T.G., Scotlandi K., Soule T., Stacchiotti S., Valverde C., Waisberg F., Zamora Estrada E., Martin-Broto J.. Corrigendum to “SELNET clinical practice guidelines for soft tissue sarcoma and GIST” [Cancer Treat. Rev. 102 (2021) 102312] (Cancer Treatment Reviews (2022) 102, (S0305737221001602), (10.1016/j.ctrv.2021.102312)). CANCER TREATMENT REVIEWS. 2023; 115DOI:10.1016/j.ctrv.2023.102523. PMID:36796283. IF:9.600(Q1/1D).